Workflow
向特定对象发行股票
icon
Search documents
北京神州细胞生物技术集团股份公司 关于2025年度向特定对象发行股票申请获得 中国证券监督管理委员会同意注册批复的公告
Core Viewpoint - Beijing Sinocell Biotechnology Group Co., Ltd. has received approval from the China Securities Regulatory Commission for its application to issue shares to specific investors for the year 2025 [1][3]. Group 1 - The company has been granted registration approval for the issuance of shares to specific investors, as per the approval document issued by the China Securities Regulatory Commission [1]. - The issuance must strictly follow the declaration documents and issuance plan submitted to the Shanghai Stock Exchange [2]. - The approval is valid for 12 months from the date of registration consent, and the company must report any significant events to the Shanghai Stock Exchange before the issuance is completed [3]. Group 2 - The company’s board will handle the issuance matters within the stipulated timeframe and fulfill information disclosure obligations as required by the approval document and relevant laws [3]. - Contact information for the company and its sponsor (lead underwriter) is provided for investor inquiries [4]. - The announcement was made by the board of directors of Beijing Sinocell Biotechnology Group Co., Ltd. on January 6, 2026 [5].
亏损股恒实科技终止定增易主深圳国资落空 拟增实控人
Zhong Guo Jing Ji Wang· 2026-01-06 03:19
中国经济网北京1月6日讯恒实科技(300513)(300513.SZ)昨晚披露了关于控股股东、实际控制人签署 《合作框架协议书》《一致行动协议书》《股票质押合同》暨控制权发生变更的提示性公告。 恒实科技2023年3月14日披露的2022年度向特定对象发行股票预案(修订稿)显示,本次发行募集资金总 额为67,108.00万元(含发行费用),扣除发行费用后募集资金净额拟用于"能源聚合商运营管控技术支撑 平台、虚拟电厂交易运营技术支撑平台、碳排放大数据管理运营技术支撑平台、补充流动资金及偿还银 行贷款"。 据恒实科技公告,公司控股股东、实际控制人钱苏晋、张小红于2026年1月5日与持公司股份1.32%的股 东新基信息技术集团股份有限公司(以下简称"新基集团")签署了《合作框架协议书》《一致行动协议 书》《股票质押合同》。基于战略合作,钱苏晋、张小红与新基集团约定保持一致行动关系。双方均同 意在具备法定转让条件后,由钱苏晋、张小红通过协议转让方式向新基集团转让当前所持恒实科技股 票,且转让股票比例不低于恒实科技当前总股本的5%。同时,钱苏晋、张小红拟将其持有的可供质押 的13,799,377股股份质押给新基集团。 截 ...
广东博力威科技股份有限公司2026年第一次临时股东会决议公告
证券代码:688345 证券简称:博力威 公告编号:2026-001 广东博力威科技股份有限公司2026年第一次临时股东会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容的 真实性、准确性和完整性依法承担法律责任。 重要内容提示: ● 本次会议是否有被否决议案:无 一、会议召开和出席情况 (一)股东会召开的时间:2026年1月5日 (二)股东会召开的地点:广东省东莞市东城街道同欢路6号公司会议室 (三)出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及其持有表决权数量的情 况: ■ 注:截至本次股东会股权登记日,公司回购专用账户中股份数为308,860股,不享有股东会表决权。 (四)表决方式是否符合《公司法》及公司章程的规定,股东会主持情况等。 本次会议由董事会召集,董事长张志平先生主持。 采用现场投票和网络投票相结合的方式进行表决。 本次会议的召集和召开程序、表决方法和表决程序均符合《中华人民共和国公司法》及《广东博力威科 技股份有限公司章程》的规定,会议合法有效。 (五)公司董事和董事会秘书的列席情况 1、公司在任董事5人,列席5人; 2、公司 ...
股市必读:中油工程(600339)1月5日主力资金净流出476.88万元,占总成交额2.23%
Sou Hu Cai Jing· 2026-01-05 20:10
Core Viewpoint - China Petroleum Engineering Corporation (中油工程) is planning to issue A-shares to a specific group, primarily to its controlling shareholder, China National Petroleum Corporation, to raise funds for oil and gas transportation projects in Iraq and the UAE, as well as to supplement working capital [1][2][3][4]. Trading Information Summary - As of January 5, 2026, the stock closed at 3.34 yuan, down 0.3%, with a turnover rate of 1.13%, a trading volume of 632,700 shares, and a transaction value of 213 million yuan [1]. - On the same day, the net outflow of main funds was 4.77 million yuan, accounting for 2.23% of the total transaction value, while retail investors saw a net inflow of 5.97 million yuan, representing 2.8% of the total transaction value [1]. Company Announcement Summary - Beijing Jindu Law Firm issued a legal opinion confirming that China Petroleum Engineering Corporation meets the conditions for issuing A-shares to specific entities. The issuance has been approved by the board of directors, shareholders, and the controlling shareholder, with a price set at 3.52 yuan per share [1]. - The financial report and audit report from ShineWing Certified Public Accountants confirmed that the financial statements of China Petroleum Engineering Corporation for the year 2024 fairly reflect its financial status and operating results [1]. Fundraising Details - The issuance aims to raise no more than 5.896 billion yuan, with the funds allocated for oil and gas transportation projects in Iraq and the UAE, as well as for working capital [2][3][4]. - The number of shares to be issued is capped at 1,674,944,241 shares, with a lock-up period of 36 months [2][5].
浙江中欣氟材股份有限公司关于2025年度以简易程序向特定对象发行股票预案及相关文件修订说明的公告
登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码:002915 证券简称:中欣氟材 公告编号:2025-089 浙江中欣氟材股份有限公司关于2025年度以简易程序向特定对象发行股票预案及相关文件修订说明的公 告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述或重大遗 漏。 浙江中欣氟材股份有限公司(以下简称"公司")于2025年12月31日召开第七届董事会第五次会议,审议 通过了《关于公司2025年度以简易程序向特定对象发行股票预案(二次修订稿)的议案》等议案,并对 本次以简易程序向特定对象发行股票的相关文件进行了修订。具体情况如下: 根据公司2024年年度股东会的授权,本次发行预案及相关文件的修订无需提交公司股东会审议。本次发 行预案及相关文件主要修订情况如下: ■ 具体内容详见公司同日在《证券时报》《证券日报》《中国证券报》《上海证券报》和巨潮资讯网 (http://www.cninfo.com.cn)披露的《浙江中欣氟材股份有限公司2025年度以简易程序向特定对象发行 股票预案(二次修订稿)》《浙江中欣氟材股份有限公司2025年度以简易程序向特定对象发行股票 ...
北特科技向特定对象发行A股股票申请获证监会同意注册批复
Zhi Tong Cai Jing· 2026-01-05 14:17
Group 1 - The core point of the article is that Beite Technology (603009.SH) has received approval from the China Securities Regulatory Commission (CSRC) for its application to issue stocks to specific investors [1] Group 2 - The approval is documented in the CSRC's official notice, reference number 2965, dated 2025 [1]
每周股票复盘:长华化学(301518)获证监会注册批复
Sou Hu Cai Jing· 2026-01-02 18:59
Core Viewpoint - Changhua Chemical (301518) has shown a positive stock performance, closing at 35.57 yuan, a 2.74% increase from the previous week, with a total market capitalization of 4.986 billion yuan as of December 31, 2025 [1] Company Announcements - The company held its fourth board meeting on December 29, 2025, where it approved the estimated amount for daily related transactions for 2026, which is expected to be no more than 59.5 million yuan [2][3] - The related transactions will involve sales of products, procurement of goods, provision of services, and rental of properties with pricing based on market principles, ensuring no impact on the company's independence or shareholder interests [2][3] - The independent directors and the sponsor institution have approved the related transactions, which do not require submission to the shareholders' meeting for approval [2][3] Fundraising and Projects - Changhua Chemical has received approval from the China Securities Regulatory Commission for a simplified procedure to issue shares to specific investors, aiming to raise approximately 155.3 million yuan for the first phase of a carbon dioxide polyether project [4][5] - The share issuance will involve 5,291,311 shares at a price of 29.35 yuan per share, with the project expected to have an annual production capacity of 80,000 tons of carbon dioxide polyether [4][5]
每周股票复盘:汇得科技(603192)股价异动因发行股票获上交所通过
Sou Hu Cai Jing· 2026-01-01 17:22
截至2025年12月26日收盘,汇得科技(603192)报收于23.74元,较上周的23.76元下跌0.08%。本周, 汇得科技12月26日盘中最高价报24.28元。12月22日盘中最低价报23.66元。汇得科技当前最新总市值 37.2亿元,在化学制品板块市值排名121/170,在两市A股市值排名4103/5181。 本周关注点 交易信息汇总 汇得科技(603192)因有价格涨跌幅限制的日收盘价格跌幅偏离值达到7%,于2025年12月31日登上沪 深交易所龙虎榜,为近5个交易日内第2次上榜。 此前,因非ST、*ST证券连续三个交易日内收盘价格涨幅偏离值累计达20%,公司已于2025年12月30日 首次上榜。 公司公告汇总 上海汇得科技股份有限公司于2025年12月29日收到上交所通知,其向特定对象发行股票申请符合发行条 件、上市条件和信息披露要求,已获审核通过,后续将报中国证监会注册。该事项最终能否获批存在不 确定性。 公司股票于2025年12月29日及30日连续两日涨幅偏离值累计超20%,构成交易异常波动。经自查及问询 控股股东与实控人,除前述发行预案外,无其他应披露未披露的重大事项。 控股股东上海汇得企业 ...
中华企业:向特定对象发行A股股票申请获得上海证券交易所审核通过
Ge Long Hui· 2025-12-31 08:22
公司本次向特定对象发行股票事项尚需中国证券监督管理委员会作出同意注册决定后方可实施,最终能 否获得中国证监会同意注册的决定及其时间尚存在不确定性。 财经频道更多独家策划、专家专栏,免费查阅>>责任编辑:十八 中华企业(600675.SH)公布,公司于近日收到上海证券交易所上市审核中心出具的《关于中华企业股份 有限公司向特定对象发行股票审核意见的通知》。根据审核结果,公司向特定对象发行股票申请符合发 行条件、上市条件和信息披露要求。 ...
山高环能集团股份有限公司关于向特定对象发行股票提交募集说明书(注册稿)等申请文件的提示性公告
Core Viewpoint - The company, Shandong Huanyu Energy Group Co., Ltd., has submitted an application for a specific stock issuance to the Shenzhen Stock Exchange, which has been approved for review [1][2]. Group 1 - The application for the issuance of stocks to specific targets was approved by the Shenzhen Stock Exchange on December 24, 2025 [1]. - The company has updated and revised the prospectus and related application documents in accordance with its actual situation and relevant review requirements [1]. - The company will disclose further information regarding the stock issuance process and any updates as necessary [2]. Group 2 - The implementation of the stock issuance is contingent upon receiving approval from the China Securities Regulatory Commission (CSRC) [2]. - There is uncertainty regarding whether the CSRC will grant approval for the registration and the timing of such approval [2]. - The company emphasizes the importance of investors making cautious decisions and staying informed about investment risks [2].